Interestingly, several molecular markers (BRAF and PI3KCA, to cite some) have been found to be predictors of colon cancer risk and mortality in relation to aspirin and anti-inflammatory drugs consumption. The gene discussed is BRAF; the disease is malignant colon neoplasm.